Research Assistant - New Platform for Next-Generation Intraocular Biologics (NIB)

About the role

BioMed X is a leading innovation engine where disruptive ideas in biomedical research and development come to life. With a global network of research institutes and venture-creating incubators embedded within major innovation hubs, BioMed X bridges the gap between academic research and the needs of the pharmaceutical industry, applying design thinking and crowdsourcing to drug discovery. The XSeed Labs site is located on the research campus of Boehringer Ingelheim in Ridgefield, Connecticut, USA. Team NIB focuses on developing an innovative human organotypic in vitro platform technology for next‑generation intraocular biologics, aiming to extend the time between intraocular injections while maintaining deep retinal penetration. The role is for a research assistant to contribute to the project on development of a novel in vitro human retina model.

Requirements

• Eligible to work in the United States.
• BSc and MSc in cell biology, developmental biology, or bioengineering (or equivalent academic/industry laboratory experience); MSc preferred.
• Experience in mammalian cell culture and general molecular biology techniques.

Skills

• Hands‑on experience in mammalian cell culture, preferably with retinal cell models and/or induced pluripotent stem cells (iPSCs).
• Experience with microphysiological systems (MPS), organ‑on‑chip platforms, and biomaterials (highly desirable).
• Expertise in at least two of the following areas: Molecular and Cellular Biology; Microphysiological systems (MPS), organ‑on‑chip platforms, and biomaterials; Retinal Biology and Human In Vitro Models; Assay Development, Screening, and Platform Engineering; Drug Delivery and Pharmacokinetics (excluding formulation development); Translational Research and In Vivo Validation; Protein Engineering and Biologics Design.
• Strong experimental, analytical, and problem‑solving skills.
• Collaborative team player with adaptability, scientific curiosity, and a desire to learn and implement new techniques.

Benefits

• Fully funded by Boehringer Ingelheim.
• Initial contract of 2.5 years with possibility to extend, starting September 2026.
• International, diverse, and positive work atmosphere with a flexible working environment.
• Access to a vast scientific network.

Pay

NIH‑aligned salary with employee benefits plan.